HealthCureVac Only 47% Effective, Fails COVID-19 Vaccine Trial CureVac fails a crucial COVID-19 vaccine trial after a late-stage study showed that its efficacy is only at 47%by Isabella James
HealthmRNAs Are The Future of Vaccines After Pfizer, Moderna's Success Against COVID—HIV, Cancers Next-in-Lineby Isaiah Richard
HealthCOVID-19 Vaccine Boosters Needed as Early as September With Pfizer. Moderna CEO Aims to Deliver By Year's Endby Isaiah Richard
HealthUS to Gain Leverage on Big Pharma-- Scientist, Developer of Pfizer’s Key Vaccine Tech Says His Reason Behind Joining NIHby Gabrielle N.
HealthFDA, CDC Halts J&J COVID-19 Vaccine's Use: Vaccinated People With These Symptoms Advised to Contact Health Expertsby Giuliano J. de Leon
HealthAlgorithm Used by Netflix, Facebook Trained to 'Predict' and Crack the 'Biological Language' of Cancer, Alzheimer'sby Lee Mercado
HealthCOVID-19: Are Germ-Killing Seats Effective? Trains in Canada Upgraded to Protect Riders From Coronavirusby Isaiah Alonzo